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Abstract
Background: Atypical scrapie was first identified in Norwegian sheep in 1998 and has subsequently been
identified in many countries. Retrospective studies have identified cases predating the initial identification of this
form of scrapie, and epidemiological studies have indicated that it does not conform to the behaviour of an
infectious disease, giving rise to the hypothesis that it represents spontaneous disease.
However, atypical scrapie isolates have been shown to be infectious experimentally, through intracerebral inocula-
tion in transgenic mice and sheep. The first successful challenge of a sheep with ‘field’ atypical scrapie from an
homologous donor sheep was reported in 2007.
Results: This study demonstrates that atypical scrapie has distinct clinical, pathological and biochemical
characteristics which are maintained on transmission and sub-passage, and which are distinct from other strains of
transmissible spongiform encephalopathies in the same host genotype.
Conclusions: Atypical scrapie is consistently transmissible within AHQ homozygous sheep, and the disease
phenotype is preserved on sub-passage.
Background
Atypical scrapie was first identified in Norwegian sheep
in 1998 [1], and has subsequently been identified in
many European countries [2] and elsewhere around the
world, including North America [3] and the Falkland
Islands [4]. Retrospective studies have identified cases
predating this initial identification [5,6] and epidemiolo-
gical studies have indicated that this form of scrapie
does not conform to the behaviour of an infectious dis-
ease [7]. In many cases, atypical scrapie does not co-
exist with classical scrapie (e.g. on individual farms, but
also at a national level, such as in Portugal and the Falk-
land Islands [8]), although some field cases originate
from flocks which have also reported classical scrapie,
and it has occurred in a closed research flock with ende-
mic classical disease [9]. It has also been reported in a
research flock in which detailed biosecurity measures
have been maintained, founded with sheep from a coun-
t r yf r e eo fc l a s s i c a ls c r a p i e[ 1 0 ] .T h i sh a sl e dt o
proposals [2,10,11] that this form of scrapie is in fact a
spontaneous disease which may have existed undetected
for a long time.
Despite lack of evidence for infectivity in the epide-
miological data, atypical scrapie isolates have been
shown to be infectious experimentally, through intracer-
ebral inoculation into ovinised transgenic mice [12] and
sheep [13].
The interactions of host and infecting strain on ovine
transmissible spongiform encephalopathies (TSEs) are
known to be complex, and have a profound effect on
the resulting phenotype of disease. Following experi-
mental challenges distinct ‘strain’ characteristics can be
identified [14], but when naturally-occurring disease is
studied it is clear that host prion protein gene (PRNP)
genotype can have a significant effect on the resulting
phenotype [15], although a single genotype may support
more than one phenotype [15,16]. The preferred geno-
type ‘target’ range of atypical scrapie is different to that
of classical scrapie [17,18] but there is some overlap in
susceptible genotypes. * Correspondence: m.m.simmons@vla.defra.gsi.gov.uk
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and immunopathology characteristics seen in classical
scrapie [15], the pathology observed in atypical cases
appears to be much more consistent, regardless of geno-
type [1,19-21].
The first successful challenge of an AHQ/AHQ sheep
with ‘field’ atypical scrapie from an homologous donor
sheep was reported in 2007 [13]. This paper provides
data on further homologous AHQ/AHQ transmissions,
including sub-passage of the initial case, and compares
this with similar data from field cases of classical scra-
pie, and experimental bovine spongiform encephalopa-
thy (BSE) in the same genotype.
Results
Full details of all the animals presented in this paper are
given in Table 1. In addition to the AHQ/AHQ animals
intracerebrally challenged with atypical scrapie (cases 1-9),
data is presented on the experimental classical scrapie
positive control animals which were also intracerebrally
challenged (cases 18-20).
The scale of such studies, and the limited availability
of both inoculum and recipient sheep precludes a study
design which includes every genotype/strain/route of
challenge combination. To enable us to assess the ability
of a single PRNP genotype to support various TSEs with
distinct pathological characteristics, data is presented for
comparison from AHQ/AHQ animals orally challenged
with BSE (cases 10-14) [22-24] and field cases of classi-
cal scrapie which have arisen naturally in AHQ/AHQ
sheep (cases 15-17) [25,26].
Animals challenged with field atypical scrapie suc-
cumbed to disease from 378 - 1057 days post challenge
(mean 751 days), which compares with 126, 537 and
605 days for the one VRQ/VRQ and two ARQ/VRQ
classical scrapie intracerebrally inoculated controls
respectively.
Clinical
Full details of the clinical signs displayed by each animal
are given in Table 1. Unlike classical scrapie and ovine
BSE, atypical scrapie did not appear to present with any
signs of pruritus. Ataxia was observed in all atypical
scrapie cases. Four of nine atypical cases displayed signs
of an asymmetric lesion distribution in the brain, such
as circling to one side and a unilateral absent menace
response. This was however not consistently displayed
in all animals inoculated with the same material.
Pathology and immunohistochemistry
Both the vacuolation profiles and immunopathological
characteristics were very consistent within the animals
challenged with atypical scrapie, and distinct from the
other AHQ/AHQ animals where disease was attributa-
ble to other strains.
Full vacuolation profiles could only be obtained for
four of the five primary transmission cases, and one
sub-passage animal. Vacuolation (Figures 1a, b) in the
atypical cases was absent in the brainstem, and most
pronounced in the cerebellar and cerebral cortices, as
compared to the BSE and classical scrapie cases in
which brainstem lesions were predominant. In the thala-
mic and frontal areas the main difference between the
classical scrapie and BSE profiles related to the relative
intensity of vacuolation, which was greater in the classi-
cal scrapie cases.
Immunohistochemistry (IHC; Figure 2) shows that
immunolabelling patterns are also distinct, with both
the type of labelling and the neuroanatomical distribu-
tion being different for the atypical scrapie compared to
the other strains. However, the atypical scrapie pattern
remains the same on primary versus secondary passage
(Figure 3), and is consistent with the IHC patterns
described in natural disease [20].
Western immunoblotting (WB; Figure 4) shows that
the banding pattern associated with atypical scrapie
[1,27] is present in all the atypical challenged cases, and
is consistent regardless of whether it is primary or sec-
ondary passage (Figure 4). The blot of the field case
which was examined in the context of a retrospective
review of natural disease [28] was consistent with classi-
cal scrapie. The BSE cases were blotted within the remit
of their source project (Chaplin and Bellworthy, unpub-
lished data), and conform to the blot pattern (low mole-
cular mass of the unglycosylated band with antibody
6H4 and a weak P4 antibody reaction) associated with
experimental BSE in sheep.
No immunolabelling was seen in any lymphoid tissue
from the atypical challenged sheep, despite widespread
involvement of the equivalent tissues in the positive
classical scrapie controls and the BSE-challenged sheep
(Table 2).
Discussion
This data confirms the experimental transmissibility
of atypical scrapie, and the stability of disease phenotype -
clinical, biochemical and pathological - on PRNP
homologous experimental transmission in AHQ/AHQ
animals. The mean incubation time of these cases (751
days) is approximately 50% of the average age at death
in field cases with atypical scrapie [20]. This observation
that intracerebral challenge shortens the incubation per-
iod is consistent with the substantial reductions in incu-
bation period which are seen in the classical scrapie
controls which are 90% (for VRQ/VRQ) and 60% (for
VRQ/ARQ) less than the average age at onset of field
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Page 2 of 10Table 1 Individual case data of genotype, breed, inoculum, route of inoculation, incubation periods and clinical signs
Case
no
Breed/genotype Challenged with Route Age at
challenge
(months)
Ip (days) Clinical signs
1* Cheviot AHQ/
AHQ
AHQ -atypical
passive (PG1347/
04) Portland
Intracerebral 5.5 378 Behavioural changes (confusion, separation from others),
compulsive behaviour (spontaneous nibbling, circling
clockwise), mild hind limb ataxia, weight loss, normal
menace response, no signs of pruritus
2 Cheviot AHQ/
AHQ
As above Intracerebral 5.5 1057 Compulsive behaviour (circling anti-clockwise), absent
menace response in the left eye, head tremor, general
ataxia, no weight loss, no signs of pruritus
3 Cheviot AHQ/
AHQ
Active surveillance
- breed not
known
Intracerebral 5.5 878 Behavioural change (nervousness), bilateral absent menace
response, head tremor, general ataxia, minor weight loss
4 Cheviot AHQ/
AHQ
Same case as
above
Intracerebral 6 990 Behavioural changes (confusion, separation from others),
bilateral absent menace response, head tremor, general
ataxia, no weight loss, no signs of pruritus
5 Cheviot AHQ/
AHQ
Subpassage of
material from
case 1
Intracerebral 3 667 No behavioural changes, bilateral absent menace response,
general ataxia, no weight loss, no signs of pruritus
6 Cheviot AHQ/
AHQ
Subpassage of
material from
case 1
Intracerebral 3 747 Compulsive behaviour (circling anti-clockwise), bilateral
absent menace response, head tremor, general ataxia &
hypermetria, minor weight loss, no signs of pruritus
7 Cheviot AHQ/
AHQ
Subpassage of
material from
case 1
Intracerebral 3 671 Behavioural changes (confusion), bilateral absent menace
response, head tremor, general ataxia, minor weight loss,
no signs of pruritus
8 Cheviot AHQ/
AHQ
(PG519/06) AHQ/
AHQ passive case
- Cheviot
Intracerebral 3 607 Behaviour changes (dullness, teeth grinding), normal
menace response, head tremor, general ataxia, weight loss,
no signs of pruritus
9 Cheviot AHQ/
AHQ
(PG519/06) AHQ/
AHQ passive case
- Cheviot
Intracerebral 3 833 Behavioural changes (confusion, separation from others),
compulsive behaviour (circling anti-clockwise), normal
menace response, general ataxia, minor weight loss, no
signs of pruritus
10 Cheviot AHQ/
AHQ
Bovine BSE oral 4 573 Abnormal behaviour (confusion), signs of pruritus (frequent
rubbing, positive scratch test, wool loss), mild ataxia
11 Cheviot AHQ/
AHQ
Bovine BSE oral 4.5 595 Head tremor, signs of pruritus (frequent rubbing, wool loss,
positive scratch test), minor weight loss
12 Cheviot AHQ/
AHQ
Bovine BSE oral 4.5 617 Signs of pruritus (wool loss), weight loss
13 Cheviot AHQ/
AHQ
Bovine BSE oral 8 642 Abnormal behaviour (separation from others), normal
menace response, head tremor, signs or pruritus (frequent
rubbing), mild ataxia, weight loss
14 Cheviot AHQ/
AHQ
Bovine BSE oral 4.5 664 Abnormal behaviour (teeth grinding), signs of pruritus
(frequent rubbing, wool loss), weight loss
15 British milksheep
X Finn Dorset
AHQ/AHQ
Classical scrapie Natural Not
applicable
9 years at
clinical onset
Abnormal behaviour (teeth grinding), ataxia, no signs of
pruritus
16 British milksheep
X Finn Dorset
AHQ/AHQ
Classical scrapie Natural Not
applicable
5 years at
clinical onset
No behavioural abnormalities, mild ataxia, pruritus (positive
scratch test)
17 British milksheep
X Finn Dorset
AHQ/AHQ
Classical scrapie Natural Not
applicable
3 years 9
months at
clinical onset
No behavioural abnormalities, mild ataxia, signs of pruritus
(frequent rubbing)
18 Cheviot ARQ/
VRQ
Classical scrapie Intracerebral 10 537 Abnormal behaviour (nervousness, separation from others),
normal menace response, head & body tremor, signs of
pruritus (positive scratch test, rubbing with nibble reflex),
ataxia, weight loss
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Page 3 of 10cases (Ortiz-Pelaez, personal communication) in these
genotypes.
There was a slight shortening of mean incubation per-
iod between the initial experimentally challenged sheep
(790 days) and those which succumbed following sub-
passage (695 days), but the group sizes are too small to
draw any robust conclusions from this observation.
The wide range of incubation periods seen cannot be
readily interpreted due to the very small numbers of
animals in this study (a necessary restriction due to the
very limited amount of suitable donor material, and lim-
ited number of recipients of a suitable genotype). It is
interesting to note that the outliers (cases 1 and 2,
Table 1) received the same inoculum. All donor inocula
Table 1: Individual case data of genotype, breed, inoculum, route of inoculation, incubation periods and clinical signs
(Continued)
19 Dorset ARQ/VRQ Classical scrapie Intracerebral 10 605 Abnormal behaviour (nervousness), normal menace
response, head tremor, signs of pruritus (rubbing with
nibble reflex), mild ataxia, weight loss
20 Dorset VRQ/VRQ Classical scrapie Intracerebral 11 126 Abnormal behaviour (dullness), absent menace response in
the eye, signs of pruritus (positive scratch test, frequent
rubbing), hind limb ataxia, minor weight loss
Ip = incubation period.
* This case previously reported [13].
Figure 1 Vacuolation profiles for atypical scrapie, classical scrapie and BSE in AHQ/AHQ sheep. See Table 1 for details of the cases, and
Table 3 for area code key, and mean ± SD for each data point. a) The profiles for the classical scrapie (pink, cases 15-17) and ovine BSE (blue,
cases 10-14) cases are similar, particularly in terms of brainstem involvement, whereas the atypical scrapie profile (green, cases 1-9) has distinctive
peaks in the cerebellum (area 12) and frontal cortex (area 20). b) The vacuolation profiles for experimental atypical scrapie cases subdivided by
passage. The profile from the original challenged animals (green, cases 1-4 and 8-9) is very similar to that in the animals that succumbed to
disease following sub-passage (red, cases 5-7).
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Page 4 of 10give similar incubation periods in ovinised transgenic
(Tg338) mice when inoculated as part of a separate
study (Spiropoulos, personal communication), although
some difference in titre is likely to be masked by the
sensitivity of these mice. In one titration of an atypical
scrapie isolate the mean incubation period did not
change more than 10% over the first three log dilutions
(Spiropoulos and Simmons, unpublished data).
The absence of any visible lymphoreticular system
(LRS) involvement in the experimentally challenged ani-
mals is consistent with what has been observed in nat-
ural cases of atypical scrapie [13] and cannot be
Figure 2 PrP
Sc deposition pattern (PDP) maps for atypical scrapie, classical scrapie, and BSE in AHQ/AHQ sheep.N o t et h a t ,i n
comparison to classical scrapie and ovine BSE, the atypical scrapie cases have relatively sparse immunolabelling in the obex and rostral midbrain,
widespread and prominent immunolabelling in the cerebellar cortex and white matter, sparse immunolabelling in the hypothalamus, and
prominent immunolabelling in the neocortex and cortical white matter.
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the classical scrapie controls challenged by the same
route had widespread labelling of disease-associated PrP
(PrP
Sc) in the lymphoid tissues.
The clinical presentation of atypical scrapie cases was
different to classical scrapie or BSE in sheep: atypical
scrapie did not appear to cause evident pruritus, whereas
the scrapie and BSE cases described here usually pre-
sented with pruritus. Compulsive behaviour, such as cir-
cling, was only observed in atypical scrapie, and an
impaired menace response was considerably more fre-
quent in atypical scrapie cases. The difference in the clin-
ical picture does not appear to be confined to the
genotype or the route of inoculation since similar signs
in the absence of pruritus have been observed in natu-
rally affected atypical scrapie cases of various genotypes
[1,10,29], whereas pruritus is frequent in naturally
affected classical scrapie cases [26] or sheep orally chal-
lenged or naturally infected with the BSE agent under
experimental settings [24]. Ataxia with hypermetria, head
tremor and an absent menace response, which were pre-
dominantly observed in sheep with atypical scrapie, are
signs indicative of a dysfunction of the cerebellum [30].
This concurs with the lesion and PrP
Sc immunolabelling
pattern distribution in atypical scrapie, which is particu-
larly prominent in the cerebellum. However, the laterali-
sation of clinical signs (circling to one side or a
unilaterally deficient menace r e s p o n s e )s e e ni na t y p i c a l
scrapie is unusual and to the authors’ knowledge has not
been described elsewhere in ovine BSE or classical scra-
pie. It is unlikely that the intracerebral route was respon-
sible for the apparent lateralisation of clinical signs
because it was not observed in ovine cases of BSE [24]
and classical scrapie inoculated by the same route (cases
18-20, Table 1). Compulsive circling in the absence of
vestibular signs like head tilt and nystagmus is suggestive
of an asymmetric lesion of the forebrain, usually on the
Figure 3 Immunolabelling in atypical scrapie cases. Immunolabelling characteristics in atypical scrapie are unchanged in natural disease (a-c),
and primary (d-f) and secondary (g-i) passage. Note the characteristic three-band pattern in the neocortex (a, d, g); prominent immunolabelling
in the molecular and granular cell layers of the cerebellum (b, e, h); prominent fine granular immunolabelling in the basal nuclei (c, f, i).
  1 2  3 4 5  6 7 8 9  10
20.1 kDa
29 kDa
Figure 4 Western immunoblot of caudal medulla of the
atypical scrapie cases. WB using monoclonal antibody Sha31,
showing the consistency of blot characteristics between field case,
experimental and sub-passaged atypical scrapie. Lanes 1 and 10
Biotinylated markers. Lane 2 Case 4. Lane 3 Case 8 (the sub-passage
of Case 4). Lanes 4 and 5 Cases 7 and 5, both sub-passages of Case
1 (not shown). Lane 6 Field case atypical scrapie positive control.
Lane 7 Field case classical scrapie control. Lane 8 Bovine BSE
positive control. Lane 9 Scrapie negative control.
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Page 6 of 10same side as the circling direction [31]. A unilateral
absent menace response has been associated with a uni-
lateral cerebellar lesion on the same side as the deficit
[32]. This would suggest that the signs in case 2 (Table
1), which presented with a left absent menace response
and circling to the left, was predominantly caused by a
lesion of the left side of the brain. Unfortunately, the
whole brain of this case was not available to evaluate
symmetry of neuropathological changes, but there was
no evidence of any pronounced asymmetrical lesion or
PrP
Sc distribution in the bilateral sections examined in
case 6, which also circled to the left.
Conclusions
T h i ss t u d ys h o w st h a tas i n g l ePRNP genotype, AHQ/
AHQ can display a range of disease phenotypes which
are consistent and readily distinguishable from each
other, supporting the suggestion that such characteris-
tics can be attributable, predominantly, to the agent
strain. However, the relative over-representation of the
AHQ genotype in the atypical naturally-affected popula-
tions supports the hypothesis that field strains have
strong genotype ‘tropisms’ or that there is genotype
selection of strains, as proposed by Spiropoulos [15].
The consistent disease phenotype seen in natural dis-
ease, primary experimental transmission and subsequent
passage, supports the experimental inoculation model as
a valid tool for the study of atypical scrapie, regardless
of whether the disease in the field is acquired or sponta-
neous. It also enables the creation of atypical scrapie
samples in a consistent manner for test evaluation and/
or quality assurance purposes, helping to improve sur-
veillance approaches for disease detection and confirma-
tion in the field.
Methods
Animals
Full details of all the animals used in this study are
given in Table 1.
Six of the cases challenged with atypical scrapie (cases
1-6, Table 1) form part of a larger transmission study
which has been described elsewhere [13] in which var-
ious homologous and cross-genotype challenges have
been initiated by both the oral and intracerebral route.
The other three challenges (cases 7-9, Table 1) were
undertaken for the principal purpose of tissue produc-
tion for use in test evaluation and quality assurance pur-
poses for the European Community Reference
Laboratory for TSE, and only brainstem, cerebellum and
basal nuclei/frontal cortex were collected into fixative
for the purpose of confirming disease.
In total, nine homologous AHQ/AHQ to AHQ/AHQ
intracerebral challenges have been performed as part of
a larger study, one of which has already been reported
[13] and three of which (cases 5-7) were sub-passages of
this first case. All of these, including the three sub-pas-
sage animals, have now succumbed to clinical disease.
Three positive controls were challenged by the same
method using field classical scrapie cases derived from
the active surveillance programme (cases 18-20, Table 1).
All recipient animals were sourced from the Veterinary
Laboratories Agency’s (VLA) New Zealand-derived
flock [10].
All intracerebral inoculations were carried out under
general anaesthesia, and in accordance with the United
Kingdom (UK) Animal (Scientific Procedures) Act 1986,
under Licence from the UK Government Home Office
(Project licence no: 70/5780). Such licence is only
granted following approval by the internal VLA ethical
review process as mandated by the Home Office.
For the purpose of generating equivalent data from
end-stage classical scrapie in the same PRNP genotype,
three historical cases of classical scrapie in AHQ/AHQ
sheep from a single flock (cases 15-17, Table 1), which
presented through passive surveillance [25,26], were
identified through a database query and sectioned,
stained and profiled in the same way as the atypical
cases.
Table 2 Immunolabelling results for lymphoid tissues from sheep challenged with experimental atypical or classical
scrapie
Case number 1 2 3 4 5 18 19 20
Lateral retropharnyngeal lymph node Neg Neg Neg NA Neg Pos Pos Neg
Palatine tonsil Neg NA NA Neg Neg NA NA NA
Nictitating membrane IT IT Neg Neg IT Neg IT Neg
Spleen Neg Neg Neg Neg Neg Pos Pos Pos
Mesenteric lymph node Neg Neg Neg Neg Neg Pos Pos Pos
Distal ileum - Peyer’s patches Neg Neg Neg Neg Neg Pos Pos Neg
Recto-anal mucosa associated lymphoid tissue (RAMALT) Neg Neg Neg Neg Neg Pos Pos Pos
Cases 1-5: atypical scrapie.
Cases 18-20: classical scrapie.
Neg = Negative; Pos = Positive; IT = insufficient lymphoid tissue to test; NA = sample not available.
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(orally challenged [22-24], cases 10-14, Table 1) were
available to us for comparison, and sections were simi-
larly prepared and scored.
Clinical monitoring
A neurological examination was conducted when animal
husbandry staff suspected clinical disease (for more
details, see [13]).
Pathology and immunohistochemistry
Whole brain was removed from each animal and hemi-
sected longitudinally. One half of the brain was placed
into 10% formal saline for histology, and the other half
stored at -80°C. Prompted by the clinical observations in
one case (case 6, Table 1) an additional section of cerebel-
lum and cerebrum of the ‘fresh’ half of the brain was taken
and fixed for comparison of lesion intensity and distribu-
tion with the other half of the brain. A range of lymphoid
tissues were also collected from the experimental group.
All brain tissue was routinely fixed, processed into
paraffin wax, sectioned and stained with haematoxylin
and eosin as described in detail elsewhere [16]. Full
details of the areas profiled are given in Table 3.
Immunohistochemical detection of PrP
Sc was per-
formed using mouse monoclonal antibody 2G11 (Institut
Pourquier, Montpellier, France), raised against ovine PrP
peptide sequence 146-R154 R171-182.
Tissue sections were de-waxed and rehydrated routinely.
Epitope demasking was performed by immersion of sec-
tions for 30 minutes in undiluted formic acid, then washed
in running tap water for 15 minutes, followed by autoclav-
ing at 121°C in citrate buffer pH 6.1 (8.8 mM tri-sodium
citrate dihydrate, 1.3 mM citric acid in 2 litres purified
water). Endogenous peroxidase was blocked using 3%
hydrogen peroxide (100 vol) in methanol, and washing
buffer used throughout the procedure was tris buffered
saline, supplemented with 0.2% tween20 (TBST). Primary
antibody was applied at dilution of 1/400 for 1 hour at
room temperature, with immunodetection performed
using biotinylated goat anti mouse and avidin-biotin-per-
oxidase-complex (Vector Elite, Burlingame, USA) techni-
que using diaminobenzidine chromogen prepared in
McIlvane’s citrate buffer. Sections were counterstained
Table 3 Vacuolation scores for each neuroanatomical area in each group of AHQ/AHQ cases
Mean vacuolation score (± SD)
Area Code Neuroanatomical area Atypical Primary
challenge
Atypical
Sub-passage
Classical
scrapie
Ovine BSE
(n = 4) (n = 2) (n = 3) (n = 5)
1 Dorsal nucleus of the vagus 0.00 (± 0.00) 0.00 (± 0.00) 2.33 (± 0.58) 3.20 (± 0.84)
2 Hypoglossal nucleus 0.00 (± 0.00) 0.00 (± 0.00) 0.00 (± 0.00) 0.60 (± 0.55)
3 Reticular formation 0.00 (± 0.00) 0.00 (± 0.00) 2.66 (± 0.58) 3.00 (± 0.71)
4 Midline raphe (caudal) 0.00 (± 0.00) 0.00 (± 0.00) 0.66 (± 0.58) 1.00 (± 0.82)
5 Accessory cuneate nucleus 0.00 (± 0.00) 0.00 (± 0.00) 0.00 (± 0.00) 1.00 (± 0.71)
6 Olivary nuclei 0.00 (± 0.00) 0.00 (± 0.00) 0.33 (± 0.58) 0.00 (± 0.00)
7 Vestibular complex 0.00 (± 0.00) 0.00 (± 0.00) 0.00 (± 0.00) 0.00 (± 0.00)
8 Cochlear nucleus 0.00 (± 0.00) 0.00 (± 0.00) 0.00 (± 0.00) 0.00 (± 0.00)
9 Nucleus of the spinal tract of the trigeminal nerve 0.00 (± 0.00) 0.00 (± 0.00) 1.00 (± 1.00) 1.80 (± 0.84)
10 Midline raphe (rostral) 0.00 (± 0.00) 0.00 (± 0.00) 2.33 (± 0.58) 0.67 (± 0.58)
11 Cerebellar vermis - nodulus 1.00 (± 0.82) 2.00 (± 1.41) 0.00 (± 0.00) 0.25 (± 0.50)
12 Cerebellar vermis -excluding nodulus 1.75 (± 1.26) 3.00 (± 0.00) 0.00 (± 0.00) 0.00 (± 0.00)
13 Central grey matter 0.00 (± 0.00) 0.00 (± 0.00) 2.33 (± 0.58) 1.60 (± 0.55)
14 Red nucleus 0.00 (± 0.00) 0.00 (± 0.00) 0.33 (± 0.58) 0.00 (± 0.00)
15 Substantia nigra 0.50 (± 0.58) 0.00 (± 0.00) 3.66 (± 0.58) 1.80 (± 1.30)
16 Lateral geniculate nucleus 0.00 (± 0.00) 0.00 (± 0.00) 0.66 (± 0.58) 0.20 (± 0.45)
17 Dorsomedial thalamic nuclei 0.05 (± 0.58) 0.50 (± 0.71) 3.00 (± 0.00) 1.40 (± 1.14)
18 Ventrolateral thalamic nuclei 1.00 (± 0.00) 0.00 (± 0.00) 1.66 (± 0.58) 0.00 (± 0.00)
19 Hypothalamus 0.00 (± 0.00) 0.00 (± 0.00) 3.33 (± 0.58) 1.80 (± 0.84)
20 Head of the caudate nucleus 2.50 (± 1.00) 3.00 (± 0.00) 0.66 (± 1.15) 1.20 (± 0.84)
21 Nucleus accumbens 1.00 (± 0.82) 2.00 (± 1.41) 2.00 (± 2.00) 0.40 (± 0.55)
22 Frontal cortex 2.25 (± 0.96) 3.00 (± 1.41) 0.00 (± 0.00) 0.00 (± 0.00)
See also Figure 1.
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cleared and mounted in dibutylphthalate in xylene (DPX),
before examination by light microscopy.
Vacuolation and immunohistochemistry profiles were
created using standard subjective methods as previously
described [16,20] in which the severity of vacuolar
lesions, or the type of PrP immunolabelling, is assessed
in a standard range of precise neuroanatomical areas.
Some modifications were made to the original method
[20] to accommodate the range of morphological PrP
Sc
immunolabelling types seen across the three TSE
strains. Globular and punctuate labelling types, which
have only been observed in atypical scrapie cases
[2,20,33], were not included in the calculation of the
average scores for each area. Therefore average PrP
deposition pattern scores (0 = negative to 6 = strong
positive) for each area were calculated using only the
remaining 12 immunolabelling types (intraneuronal,
intraglial, intra-astrocytic, (fine) granular, stellate, linear,
perineuronal, plaque-like, subpial, (sub)ependymal, peri-
vascular, vascular plaques).
Tissues from the LRS of each challenged animal were
examined by IHC, using the same method described
above. The effects of the intracerebral route of challenge
were controlled for by examination of the LRS from
positive control VRQ/VRQ and ARQ/VRQ animals that
had been challenged intracerebrally with classical scrapie
(cases 18-20, Table 1).
Western Immunoblot
Fresh brain samples were subjected to the TeSeE Univer-
sal WB (Bio-Rad Cat No: 355 1169 Marnes-la-Coquette,
France).
A 0.35 g tissue sample from each case was ribolysed,
purified, Proteinase K treated and PrP
Sc concentrated fol-
lowing the kit instructions and reagents supplied. Sam-
ples were heated for 4 minutes at 100°C and15 μlo fe a c h
sample was loaded in single lanes onto pre-cast 12% bis-
tris gels (Criterion, Bio-Rad) and electrophoresed for
50 minutes at 200 V. The proteins were then transferred
onto PVDF membranes (115 V for 60 minutes) and
blocked (Bio-Rad blocking solution) for 40 minutes
at room temperature. They were probed with the kit
primary antibody for 30 minutes at room temperature.
The membranes were washed, incubated for 20 min-
utes in Bio-Rad secondary antibody at room tempera-
ture, washed again and the membranes were incubated
with ECL substrate (GE Healthcare, Amersham, UK) for
45-60 seconds. The signal was detected with the Fluor-S
MultiImager (Bio-Rad).
Molecular mass markers were included at either end
of the gel. A single lane each of a known UK classical
scrapie, known UK bovine BSE and a known UK atypi-
cal scrapie case were included for profile comparisons.
Frozen material for the WB component of the study
was only available from the experimental challenges in
the current study. One of the scrapie cases was blotted
as part of the retrospective study previously reported
[28]. The other two cases were sampled before WB was
a routine approach for TSE diagnosis, so no blot data is
available from these animals.
All five ovine BSE cases were blotted using the VLA-
Hybrid Western method [28].
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